The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. SELLAS Life Sciences Group Inc shares valued at $14,800 were purchased by VAN NOSTRAND ROBERT L on Jun 12 ’25. At $1.48 per share, VAN NOSTRAND ROBERT L acquired 10,000 shares. The insider’s holdings grew to 20,400 shares worth approximately $37740.0 following the completion of this transaction.
Also, Wasman Jane purchased 20,000 shares, netting a total of over 33,800 in proceeds. Following the buying of shares at $1.69 each, the insider now holds 30,400 shares.
Before that, Kalin Katherine Bach had added 20,000 shares to its account. In a trade valued at $36,000, the Director bought SELLAS Life Sciences Group Inc shares for $1.80 each. Upon closing the transaction, the insider’s holdings increased to 20,000 shares, worth approximately $75850.0.
As published in their initiating research note from Cantor Fitzgerald on July 21, 2021, SELLAS Life Sciences Group Inc [SLS] has been an Overweight and the price target has been revised to $18. Analysts at Oppenheimer started covering the stock with ‘”an Outperform”‘ outlook in a report released in early November. As of April 02, 2018, H.C. Wainwright has initiated its “Buy” rating for SLS. Earlier on March 19, 2018, Maxim Group upgraded its rating. Their new recommendation was “a Buy” for SLS stock which previously was a “a Hold”.
Analyzing SLS Stock Performance
On last trading session,, SELLAS Life Sciences Group Inc [NASDAQ: SLS] rose 4.52% to $1.85. The stock’s lowest price that day was $1.69, but it reached a high of $1.85 in the same session. During the last five days, there has been a surge of approximately 18.59%. Over the course of the year, SELLAS Life Sciences Group Inc shares have jumped approximately 51.64%. Shares of the company reached a 52-week high of $2.1200 on 05/27/25 and a 52-week low of $0.8505 on 01/23/25.
Support And Resistance Levels for SELLAS Life Sciences Group Inc (SLS)
According to the 24-hour chart, there is a support level at 1.7433, which, if violated, would cause prices to drop to 1.6367. In the upper region, resistance lies at 1.9033. The next price resistance is at 1.9567. RSI (Relative Strength Index) is 62.52 on the 14-day chart, showing neutral technical sentiment.
Is SELLAS Life Sciences Group Inc subject to short interest?
Stocks of SELLAS Life Sciences Group Inc saw a sharp rise in short interest on 2025-05-30 jumping by 4.51 million shares to 12.22 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 7.71 million shares. A jump of 36.92% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 4.15 of the overall float, the days-to-cover ratio (short ratio) jumped to 4.15.
Which companies own the most shares of SELLAS Life Sciences Group Inc (SLS)?
In terms of SELLAS Life Sciences Group Inc share price expectations, FactSet research, analysts set an average price target of 2.8 in the next 12 months, up nearly 58.19% from the previous closing price of $1.77. Analysts anticipate SELLAS Life Sciences Group Inc stock to reach 3.2 by 2025, with the lowest price target being 2.4. In spite of this, 2 analysts ranked SELLAS Life Sciences Group Inc stock as Buy at the end of 2025.
